Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies
Technology in Cancer Research & Treatment · 2024
DOI: 10.1177/15330338241252622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Antje Wark und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Proton Therapy, Bone Marrow, Genital Neoplasms, Female. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The aim of this matched-pair cohort study was to evaluate the potential of intensity-modulated proton therapy (IMPT) for sparring of the pelvic bone marrow and thus reduction of hematotoxicity compared to intensity-modulated photon radiotherapy (IMRT) in the setting of postoperative irradiation of gynaecological malignancies. Secondary endpoint was the assessment of predictive parameters for the occurrence of sacral insufficiency fractures (SIF) when applying IMPT. Materials and Methods: Two cohorts were analyzed consisting of 25 patients each. Patients were treated with IMPT compared with IMRT and had uterine cervical (n = 8) or endometrial cancer (n = 17). Dose prescription, patient age, and diagnosis were matched. Dosimetric parameters delivered to the whole pelvic skeleton and subsites (ilium, lumbosacral, sacral, and lower pelvis) and hematological toxicity were evaluated. MRI follow-up for evaluation of SIF was only available for the IMPT group.
Results
In the IMPT group, integral dose to the pelvic skeleton was significantly lower (23.4GyRBE vs 34.3Gy; p < 0.001), the average V 5Gy , V 10Gy , and V 20Gy were reduced by 40%, 41%, and 28%, respectively, compared to the IMRT group ( p < 0.001). In particular, for subsites ilium and lower pelvis, the low dose volume was significantly lower. Hematotoxicity was significantly more common in the IMRT group (80% vs 32%; p = 0009), especially hematotoxicity ≥ CTCAE II (36% vs 8%; p = 0.037). No patient in the IMPT group experienced hematotoxicity > CTCAE II. In the IMPT cohort, 32% of patients experienced SIF. Overall SIF occurred more frequently with a total dose of 50.4 GyRBE (37.5%) compared to 45 GyRBE (22%). No significant predictive dose parameters regarding SIF could be detected aside from a trend regarding V50Gy to the lumbosacral subsite.
Conclusion
Low-dose exposure to the pelvic skeleton and thus hematotoxicity can be significantly reduced by using IMPT compared to a matched photon cohort. Sacral insufficiency fracture rates appear similar to reported rates for IMRT in the literature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
- Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
- National Center for Tumor Diseases (NCT), Heidelberg, Germany.
- All India Institute of Medical Sciences (AIIMS), New Delhi, India.
- Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany.
ORCID-Profile: Antje Wark, Eva Meixner, Kristin Lang
Zitieren
APA
Wark, A., Gupta, A., Meixner, E., König, L., Hörner-Rieber, J., Forster, T., Lang, K., Ellerbrock, M., Herfarth, K., Debus, J., & Arians, N. (2024). Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241252622
Vancouver
Wark A, Gupta A, Meixner E, König L, Hörner-Rieber J, Forster T, et al. Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241252622
BibTeX
@article{Wark2024,
author = {Wark, Antje and Gupta, Anil and Meixner, Eva and König, Laila and Hörner-Rieber, Juliane and Forster, Tobias and Lang, Kristin and Ellerbrock, Malte and Herfarth, Klaus and Debus, Jürgen and Arians, Nathalie},
title = {Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
doi = {10.1177/15330338241252622}
}
EUVIMED